RAPP Rapport Therapeutics, Inc.

NEUTRAL Impact: 2/10 DEFA14A
Horizon immediate Filed Apr 23, 2026 Processed 1mo ago SEC 0001193125-26-171836
Proxy solicitation materials
Latest settled — T+20d
RAPP ▼ -1.76% at T+20d
NEUTRAL call ✗ call lost -1.76% · α vs SPY -6.39% · entry $36.36 → $35.72
Next anchor: T+60d in 6w
Currently $35.84 · -1.43% from $36.36 entry
Entry anchored
Apr 22, 03:59 PM ET
via Databento tick
T+1d
+0.55%
call +0.55% · α -0.23%
$36.56
settled 7w ago
T+5d
-9.24%
call -9.24% · α -10.72%
$33.00
settled 6w ago
T+20d
-1.76%
call -1.76% · α -6.39%
$35.72
settled 20d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Rapport Therapeutics is holding its 2026 Annual Meeting virtually on June 10, 2026, where shareholders will vote on the election of three Class II directors and the ratification of its independent auditor.

Actionable Insight

Monitor the outcome of the shareholder vote, but expect no immediate market impact as the proposals are standard and uncontested.

Key Facts

  • The 2026 Annual Meeting will be held virtually on June 10, 2026, at 1:00 PM ET.
  • Shareholders will vote to elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors.
  • Shareholders will vote to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
  • The filing is a definitive proxy statement (DEFA14A) for the annual meeting.

Financial Impact

No direct financial impact from this filing; it is a routine corporate governance matter.

board_compositionauditor_selection

Risk Factors

  • Insider selling activity (8 sells totaling $19.2M in the past 30 days) could indicate reduced confidence, but this is not directly related to the proxy vote.
  • The routine nature of the vote means no significant governance changes are expected.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-171836
Document: 0001193125-26-171836-index-headers.html0001193125-26-171836
Document: 0001193125-26-171836-index.html0001193125-26-171836
Document: 0001193125-26-171836.txt0001193125-26-171836
10 reports for RAPP
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +24.87%Mar 10, 2026
Filters
Rows
Reports for RAPP — sortable, filterable
Type Now
May 27, 2026
13d ago
144
BEARISH ★ 5/10
$39.51 $34.90▲ +11.67%▲ +12.88%$35.84 (+9.29%)
May 11, 2026
29d ago
144
BEARISH ★ 5/10
$37.24 $35.18▲ +5.53%▲ +5.61%$35.84 (+3.76%)
May 8, 2026
4w ago
144
NEUTRAL ★ 3/10
$38.43 $35.18▼ −8.46%▼ −8.37%$35.84 (−6.74%)
May 7, 2026
4w ago
144
NEUTRAL ★ 3/10
$38.04 $37.95▼ −0.24%▼ −1.70%$35.84 (−5.78%)
May 7, 2026
4w ago
8-K
MIXED ★ 6/10
$39.93 $38.08▼ −4.63%▼ −6.14%$35.84 (−10.24%)
Apr 23, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$36.36 $33.00▼ −9.24%▼ −10.72%$35.84 (−1.43%)
Apr 21, 2026
7w ago
Press Release
BULLISH ★ 8/10
$36.78 $33.30▼ −9.48%▼ −9.53%$35.84 (−2.56%)
Apr 1, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$31.67 $34.22▲ +8.05%▲ +4.29%$35.84 (+13.17%)
Mar 30, 2026
10w ago
144
NEUTRAL ★ 3/10
$31.29 $33.69▲ +7.67%▲ +3.73%$35.84 (+14.54%)
Mar 10, 2026
13w ago
Press Release
BULLISH ★ 8/10
$29.63 $27.73▼ −6.41%▼ −5.51%$35.84 (+20.96%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (10h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access